We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
| Level: | Consumer |
|---|---|
| Class: | I |
| Reference: | R2003/1013 |
| Date agreed: | 19 September 2003 |
| Product: | Bioglan Bio Superdophilus Tablets |
| ARTG number: | AUST L 70230 |
| Batch number: | 1809-3 |
| Sponsor: | Australian Pharmaceutical Industries Limited |
| Contact: | 1300 363 032 |
| Reason: | 6 individual bottles of this batch of product subject to quarantine and recall due to their manufacture by Pan Pharmaceuticals Limited have been resupplied to the market in Australin Capital Territory in error. |
Classification system:
Class I defects are potentially life-threatening or could cause a serious risk to health.
Class II defects could cause illness or mistreatment, but are not Class I.
Class III defects may not pose a significant hazard to health, but withdrawal may be initiated for other reasons.
Class I & II recalls are considered to be safety related recalls.